Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sanders

Showing results (1211-1220 of 1,255) with videos related to

Pageof 126
Sort By:
Cancer Research|March 3, 2017
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Cell Metabolism|October 6, 2017
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative PhosphorylationKyung-Min Lee, Jennifer M Giltnane, Justin M Balko, et al.
Nature Medicine|June 12, 2012
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceJustin M Balko, Rebecca S Cook, David B Vaught, et al.
Genome Medicine|May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Current HIV Research|December 25, 2019
Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID WorkshopRamesh Akkina, Daniel L Barber, Moses T Bility, et al.
Blood|August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosisH Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Nature Cancer|May 29, 2023
Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastasesPravat Kumar Parida, Mauricio Marquez-Palencia, Suvranil Ghosh, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Cell Metabolism|January 5, 2022
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitnessPravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya Nair, et al.
Pageof 126

Showing results (1211-1220 of 1,255) with videos related to

Sort By:
Pageof 126
Cancer Research|March 3, 2017
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Cell Metabolism|October 6, 2017
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative PhosphorylationKyung-Min Lee, Jennifer M Giltnane, Justin M Balko, et al.
Nature Medicine|June 12, 2012
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceJustin M Balko, Rebecca S Cook, David B Vaught, et al.
Genome Medicine|May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Current HIV Research|December 25, 2019
Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID WorkshopRamesh Akkina, Daniel L Barber, Moses T Bility, et al.
Blood|August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosisH Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Nature Cancer|May 29, 2023
Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastasesPravat Kumar Parida, Mauricio Marquez-Palencia, Suvranil Ghosh, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Cell Metabolism|January 5, 2022
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitnessPravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya Nair, et al.
Pageof 126